The State of U.S. Cannabis Legalization in 2022
Last year was a federal bust. So, what does 2022 look like for cannabis operators looking to invest, set up shop or expand? We are deep into the first quarter of the new year, and federal legalization of cannabis remains a pipe dream, an ambition located further into the imaginable future than it seemed a year ago. 2021 was called a cannabis “nothing burger” by Forbes Magazine in its own year-end reflection on the federal cannabis legalization movement, which aptly describes the federal inactivity of last year. Federal action was initially thought by some to happen quickly after the November 2020 watershed election which brought feather-thin Democratic margins in the U.S. Congress and in which five states (all over the geographic and political map) saw cannabis legalization efforts pass with healthy voter margins. But with the world entering year three of a global pandemic, Russia invading the country of Ukraine, and Americans bickering about mask mandates, federal cannabis legalization has had to take a backseat to other major issues in the crosshairs of the Biden administration. Even though the U.S. House of Representatives at the beginning of February 2022 “advanced” provisions of the SAFE Banking Act (which would permit access to banking by cannabis businesses). That bill, like the previous SAFE banking bills, is expected to go nowhere in the U.S. Senate, however. This latest vote was the sixth such passage of the SAFE Banking Act in the House. Has the Lack of Federal Legalization Impacted the Market? This stymied and stalemated federal impasse is now obvious to cannabis multistate operators and M&A specialists. Federal legalization fervor has waned and is reflected in the market. Cannabis stock prices (once soaring) took significant hits in 2021. However, a downturn in stock value or performance does not tell an industry’s whole financial story. Brad Sodowick, a finance professor at Drexel University’s LeBow School of Business, and who teaches the “Emerging Business of Cannabis,” explained that “the failure to federally legalize is but one factor to be considered when investing in publicly traded cannabis companies. Many other variables are in play as investment in cannabis has always been risky. Thoughtful investment in this industry requires a long-term, multiyear strategy.” 
Sodowick’s strategy pointers also include looking at cannabis sales. He forecasts that “marijuana sales in legal states will continue to grow exponentially in 2022 and beyond.”
These growth predictions are not implausible as cannabis access is expanding across America. Legalization Action Is in the States—Not the Feds
Legalization remains the province of the states. Currently, there are three degrees of legalization in America. This includes four of America’s inhabited territories in the Atlantic Ocean, (Puerto Rico and the U.S. Virgin Islands (USVI)) and in the Pacific Ocean, (Guam and the Commonwealth of the Northern Mariana Islands (CNMI)). The three degrees of legalization include:
Third-degree states include those in which a state’s legislature has passed a law that grants limited access (and often with low or negligible THC content). Georgia passed such a severely-limited-access (SLA) law in 2015 , called “Hayleigh’s Hope Act” named for a young child, Hayleigh, who suffered from a debilitating seizure disorder. South Carolina’s SLA law was passed in 2014 and is named “Julian’s Law,” after a brain-damaged South Carolina infant who developed epilepsy, and who had to leave the state to travel to a legal state (Colorado) to treat the 60 seizures that were racking the child’s body. Other third-degree SLA states restrict not just the composition of the product and its medical uses, but also the manner of ingestion, the places where the product can be administered or acquired, and sometimes limit restricted access solely to research studies or institutions. The third-degree states are depicted in yellow on the legalization map. Mississippi Changes (Finally) Into a Second-Degree Medical State
The most recent evolution from a third-degree limited access state to a second-degree medical use state happened this month in Mississippi. On Feb. 2, 2022, Mississippi Gov. Tate Reeves, a Republican elected in 2019, signed medical use (second-degree) legislation into law . This ended an almost 15-month stalemate between Mississippi voters and their lawmakers. Mississippi’s new medical marijuana law places the power to add medical conditions and to issue medical marijuana licenses and registrations to the Mississippi Department of Health. The medical conditions listed on the state Department of Health website which qualify for medical marijuana include cancer, Parkinson’s, ALS, PTSD, AIDS/HIV and autism as well as other conditions associated with terminal or debilitating illnesses such as end-of-life “wasting” disease. The Mississippi Health Department expects to issue licenses to cultivation facilities, processing facilities, testing facilities, waste disposal and transportation entities within 120 days. Within 150 days, the department reports that it is expected to issue licenses to Mississippi medical marijuana dispensaries. Other SLA States Are Considering Changes in Legalization
Other severely-limited-access third-degree states are considering advancing to medical marijuana legalization. These include South Carolina and Kentucky. South Carolina
In February 2022, South Carolina’s State Senate approved a medical marijuana bill, with a 28-15 vote. The approval sends the South Carolina Compassionate Care Act to the South Carolina House of Representatives for consideration. If approved (and then signed by South Carolina’s governor), the legislation in its current form would legalize the use of medical cannabis only in oil, creams, gummies, and edibles, and would prohibit all use in any smokable or combustible dry form. Kentucky
Legislators there, in February 2022, proposed a number of marijuana bills which would legalize adult-use and medical cannabis. The Kentucky Democrats’ proposal unveiled in both chambers on Feb. 17, 2022, is called the “ LETT’s Grow Bill ” (shorthand for Legalize, Expunge, Treat & Tax). The Republican counterproposal endorses only medical cannabis, requiring certification of medical conditions by licensed medical professionals. Under the Republican proposal, at-home cultivation and the smoking of the medical cannabis would remain illegal. In December 2021, Kentucky Governor Andy Beshear (as reported by Kentucky’s Channel 44 News) stated that “Kentucky should definitely move forward with medical marijuana” and that “the law change would allow people who might otherwise turn to more damaging substances to use the drug.”
Even Exclusively Medical States Are “Making Moves” to Legalize Adult-Use Sales
In states such as Ohio, Missouri, Arkansas, South Dakota, and Oklahoma, pro-reform forces have been taking action to ensure that adult-use ballot initiatives are placed on each state’s November 2022 ballot. U.S. Rep. Tim Ryan of Ohio, at a stop-over in Southern California on Feb. 14, 2022, stated that Ohio (a medical-legal state since 2016) was expected to have adult-use legalization on the November 2022 ballot, which, he surmised, might bring out the college-age voters. Other medical-legal states, including Delaware, Minnesota, New Hampshire, Hawaii, and Rhode Island, at this time, have members of those state’s legislatures proposing and advancing adult-use cannabis legalization. And for states that use the referendum process like Maryland (in which the legislature places questions on the ballot for the voters to weigh in on) there too, lawmakers are close to placing adult-use referenda on the November 2022 ballot. The Remaining Three Fully Illegal States
As of publication, 18 states are first-degree states having legalized adult-use sales with all having co-existing medical regimes. 19 states have legalized exclusively medical use (second-degree). Ten others (third-degree states) have just severely-limited-access. This computation (totaling 47 states) leaves just three mainland states where under state law; marijuana remains “entirely illegal.”
The fully illegal states are Idaho, Kansas, and Nebraska. Idaho’s Office of Drug Policy current website states : “Marijuana is the most commonly used illicit drug in the United States.” It is “a Schedule I controlled substance under Idaho law” and “is illegal to use.”
Kansas, in 2012, passed legislation that increased penalties for drug crimes including those involving the Kansas controlled substance of marijuana. And even though the state of Nebraska reduced possession of an ounce or less of cannabis to an infraction offense, distribution of any amount remains a criminal offense punishable by imprisonment and other penalties under Nebraska law. But these anti-states are considering moves toward some degree of legalization. Idaho is dipping a toe into the severely limited access (third-degree) status with the Idaho House passing a bill to permit cannabis as a topical pain relief ingredient. In Kansas, in May 2021, the Kansas House of Representatives passed a medical marijuana bill , and sent it to a committee of the Kansas State Senate for consideration. State Senate hearings have not yet occurred, and the bill has been directed to a different Kansas State Senate panel. Nebraskans for Medical Marijuana (and other advocacy groups) are raising money and gathering signatures to have legalization of marijuana initiatives placed on the November 2022 ballot. 99% of Americans Live in a Region With Some Degree of Legalization
The U.S. has about 330 million inhabitants. Almost 99% of America’s inhabitants live in a place with some degree of legalization as reflected in this pyramid of legalization. The pyramid shows that of those 330 million, fewer than seven million live in places where marijuana is illegal under the law of the state. States Are Leading the Way. Do Your Homework and Stake Your Claim
The legalization action for the near future (meaning, at a minimum, until after the 2024 presidential election) will be occurring in the states. As a result, those seeking to start, diversify or invest in a cannabis business—should consider the laws, regulations, and practices of the states (and U.S. territories). The year 2022 will see more states come into the legalization fold – at least to some degree. With the laws (at the state and local level) changing almost weekly, operators would be well-advised to put a marijuana legalization expert on the payroll and find a state climate (figuratively and literally) that fits the bill. ----------------------------------------------------------------------------------------------------------
Julie A. Werner-Simon, a former federal prosecutor, teaches cannabis law at University of Southern California’s Gould School of Law and Drexel University’s Kline School of Law. She is also a legal analyst in the Emerging Business of Cannabis, a course at Drexel’s LeBow School of Business. Oregon shoppers who purchased vape products that were allegedly mislabeled as 100% cannabis more than two years ago can begin filing $200 claims through the settlement of a class-action lawsuit. The lawsuit claims that Cura Partners Inc. failed to disclose that 186,000 units of certain Select brand oil products contained botanical terpenes, according to case administrators, who said Feb. 27 they are ready to begin processing claims, The Oregonian reported. The claimants must be Oregon residents 21 and older who purchased products from the Select Elite, Select Pax and/or Select Dabbables product lines, including cartridges, disposable pens or pods, between Aug. 15, 2018, and Nov. 22, 2019, according to CPT Group, the case administrators. Curaleaf signed a definitive agreement to acquire Portland, Ore.-based Cura Partners and its Select brand in May 2019 in a $948.8-million all-stock deal. Curaleaf completed that acquisition in February 2020. The following year, Curaleaf became involved in a separate lawsuit for allegedly mislabeled products associated with a September 2021 recall by the Oregon Liquor and Cannabis Commission. Those products involved mislabeled CBD tinctures that actually contained THC. Those wishing to submit a claim for the recent settlement must do so by April 29, 2022. In addition to the online forms, claim forms are also available by writing to Cura Settlement, c/o CPT Group Inc., 50 Corporate Park, Irvine, CA 92606; or by emailing oregonclassactionsettlement@cptgroup.com . While the company denies it did anything wrong, and the circuit court for Multnomah County has not decided which side is right, the parties reached a $500,000 settlement . That money will provide $125,000 in plaintiff attorney fees as well as $200 for each approved claim, according to CPT Group. In addition, the defendant agreed to pay a $110,000 “dishonest conduct” penalty in January 2020, The Oregonian reported. The approximate costs of the allegedly mislabeled products at issue were $20, according to the settlement. Plaintiffs are entitled to back out of the settlement if the number of approved claims is so high that each class member would receive less than $20 each, according to the settlement. However, the settlement forecasts that fewer than 1% of those eligible will file claims because of the cash-only nature of Oregon sales as well as the products being sold through third-party retailers, The Oregonian reported. Those filing claims must show a proof of residency or proof of purchase in Oregon. The packaging on the eligible products did not include the existence of botanically derived terpenes and/or medium-chain triglyceride (MCT) as an ingredient in the product lines, according to CPT Group. Those with approved claims will receive an electronic payment or paper check. Any unclaimed funds will be split evenly between the Oregon State Bar and the Oregon Consumer League, a nonprofit advocacy organization focused on consumer protection issues

The State of U.S. Cannabis Legalization in 2022

Minnesota’s Medical Cannabis Patients Can Now Access Flower
The new law, a result of legislation that passed last year, went into effect March 1. Patients enrolled in Minnesota’s medical cannabis program can now access flower after a new law went into effect March 1, according to a CBS Minnesota report . Until now, the state’s dispensaries could only sell medical cannabis in pill, oil and topical form, but the new law, a result of legislation that passed last year, now allows them to sell smokable flower, the news outlet reported. Two dispensaries, Green Goods in Minneapolis and LeafLine in St. Paul, have been approved by the Minnesota Department of Health to sell flower, according to a KARE 11 report , and patients must apply to obtain flower. Flower will provide a cheaper alternative to other cannabis products, the news outlet reported, which will help alleviate pricing concerns in the market. “The number one complaint we have heard from patients over the years is the price point, really,” Chris Tholkes, director of the medical cannabis office within the Minnesota Department of Health, told KARE 11. “[Flower is] cheaper because it's not concentrated like wax pens." Oregon Cannabis Customers Can Collect $200 Per Claim Over Select Brand’s Mislabeled Product Settlement
The claims must be filed by April 29 and are available to those who purchased various Select products during a 15-month time period. Oregon shoppers who purchased vape products that were allegedly mislabeled as 100% cannabis more than two years ago can begin filing $200 claims through the settlement of a class-action lawsuit. The lawsuit claims that Cura Partners Inc. failed to disclose that 186,000 units of certain Select brand oil products contained botanical terpenes, according to case administrators, who said Feb. 27 they are ready to begin processing claims, The Oregonian reported. The claimants must be Oregon residents 21 and older who purchased products from the Select Elite, Select Pax and/or Select Dabbables product lines, including cartridges, disposable pens or pods, between Aug. 15, 2018, and Nov. 22, 2019, according to CPT Group, the case administrators. Curaleaf signed a definitive agreement to acquire Portland, Ore.-based Cura Partners and its Select brand in May 2019 in a $948.8-million all-stock deal. Curaleaf completed that acquisition in February 2020. The following year, Curaleaf became involved in a separate lawsuit for allegedly mislabeled products associated with a September 2021 recall by the Oregon Liquor and Cannabis Commission. Those products involved mislabeled CBD tinctures that actually contained THC. Those wishing to submit a claim for the recent settlement must do so by April 29, 2022. In addition to the online forms, claim forms are also available by writing to Cura Settlement, c/o CPT Group Inc., 50 Corporate Park, Irvine, CA 92606; or by emailing oregonclassactionsettlement@cptgroup.com . While the company denies it did anything wrong, and the circuit court for Multnomah County has not decided which side is right, the parties reached a $500,000 settlement . That money will provide $125,000 in plaintiff attorney fees as well as $200 for each approved claim, according to CPT Group. In addition, the defendant agreed to pay a $110,000 “dishonest conduct” penalty in January 2020, The Oregonian reported. The approximate costs of the allegedly mislabeled products at issue were $20, according to the settlement. Plaintiffs are entitled to back out of the settlement if the number of approved claims is so high that each class member would receive less than $20 each, according to the settlement. However, the settlement forecasts that fewer than 1% of those eligible will file claims because of the cash-only nature of Oregon sales as well as the products being sold through third-party retailers, The Oregonian reported. Those filing claims must show a proof of residency or proof of purchase in Oregon. The packaging on the eligible products did not include the existence of botanically derived terpenes and/or medium-chain triglyceride (MCT) as an ingredient in the product lines, according to CPT Group. Those with approved claims will receive an electronic payment or paper check. Any unclaimed funds will be split evenly between the Oregon State Bar and the Oregon Consumer League, a nonprofit advocacy organization focused on consumer protection issues
Chai Beckett, assistant manager at Buzz Box in Portland, Ore., considered a career in American Sign Language (ASL) before landing in the emerging cannabis industry. She had studied ASL in college, taking her coursework as far as she could, but then she found herself at a crossroads: What should she do professionally, after school? Cannabis won out, but she soon discovered that it wasn’t an either-or proposition. Last fall, Katalina B., founder of the advocacy group Human Informed Culture, reached out to Beckett to gauge her interest in a new set of ASL classes directed specifically at budtenders. Beckett jumped at the opportunity. It followed a sequence of events that had kept ASL at the very center of her life for years. “It just seemed like a really cool language to me,” she says, describing her ASL path. “I started getting really into the music scene, interpreting songs. And then it was like, ‘Why don't we have ASL taught at our school? We just have Spanish and French and German. We don't have ASL, but why not?’” From high school, where she petitioned administrators to add ASL as a course offering, through college, Beckett’s interest in the language bloomed. Then came the cannabis industry. The monthly ASL-for-cannabis classes are taught by Matt Maxey, founder of Deafinitely Dope. Prior to developing his three-tiered series of ASL classes for the cannabis space, Maxey brought his sign language skills to the music world. He’s worked with Waka Flocka Flame, Chance the Rapper and others to bring music to the hard of hearing. Maxey describes himself as “hard of hearing—severely profoundly hard of hearing.” He wears two hearing aids. “I can talk, but sign language does help to make things more clear—instead depending on technology,” he says. Music is important to him, so helping to bridge that language gap became a passion project. But so too is cannabis, and he found a way to bring his education skills to this new marketplace. “There is a genuine intent in learning how to be more accessible,” he says. “We're just trying to capitalize on that: Keep it moving, provide as many options as possible. But we’re still in the early stages.”
The demand is there, he’s quick to point out: “Everybody that I know who has a hearing loss indulges in marijuana,” he says with a laugh. In other words, for dispensary employees, it’s paramount to include that customer base’s needs in day-to-day operations. Buzz Box opened in March 2021, and Beckett says the dispensary prides itself on the surrounding neighborhood’s hyperlocal feel. It’s a tight-knit community. Dispensary interactions reflect that. “We really love to have a personalized experience with every customer and patient that comes in, which I love so much,” she says. “We just try to get specifics on what they're looking for so that we can give the right recommendations. With any category, like cartridges, extracts, flower, pre-rolls, it’s all about just asking those questions to make sure that they don't get something that's going to be too strong for them or not strong enough. We want to make sure that they know the right dosage and that it's the right effect that they're looking for.”
To do so, clear communication is required. Maxey’s classes get right to the matter at hand: framing ASL education with the typical words and phrases that make up an exchange inside a dispensary. “We learned things like ‘sativa,’ ‘hybrid,’ ‘indica,’” Beckett says. “We learned the different sizes—eighth, gram, quarter-ounce. We learned about different smells, like if it's ‘funky,’ if it's ‘sweet,’ if it's ‘lemony,’ different terpenes. Those words can really help cater the experience. Why should hearing people be the only ones to have these extraordinary experiences that are catered to them in dispensaries?”
Without the proper communication tools like ASL, deaf or partially deaf customers may be stuck merely pointing at menu items or going to the trouble of writing down their questions for the budtender. This can add a degree of discomfort to what is sometimes an already complicated commercial transaction. Cannabis can be a confusing product to navigate, especially for those who are new the market. Even knowing the basic alphabet signs can go a long way in welcoming customers who need sign language. Watch this video to learn from Maxey:
Maxey has seen a lot of success so far. ASL isn’t super difficult to learn, and budtenders have joined his classes with hopes of bringing the work back to their teams. He says Deafinitely Dope has worked with budtenders all over the U.S., across a variety of medical and adult-use markets. Demand is everywhere, even if it’s not as straightforward as it seems on first blush. “Deafness is a spectrum,” he says. “It’s not one-size-fits-all. You may have people who have hearing loss and don't know sign language. You may have people who have hearing loss and only use sign language. You may have people who really can't hear, but can hear a lot with their hearing aid. All of that is still included in the spectrum. Whether they talk, don't talk, whether they sign, they’re always trying to figure out how to communicate with you. Never assume that, ‘Oh, you’re deaf? You know sign language.’”
It's a matter of meeting customers and patients where they feel most comfortable, and being prepared to do so.

Minnesota’s Medical Cannabis Patients Can Now Access Flower

Oregon Cannabis Customers Can Collect $200 Per Claim Over Select Brand’s Mislabeled Product Settlement
The claims must be filed by April 29 and are available to those who purchased various Select products during a 15-month time period. Oregon shoppers who purchased vape products that were allegedly mislabeled as 100% cannabis more than two years ago can begin filing $200 claims through the settlement of a class-action lawsuit. The lawsuit claims that Cura Partners Inc. failed to disclose that 186,000 units of certain Select brand oil products contained botanical terpenes, according to case administrators, who said Feb. 27 they are ready to begin processing claims, The Oregonian reported. The claimants must be Oregon residents 21 and older who purchased products from the Select Elite, Select Pax and/or Select Dabbables product lines, including cartridges, disposable pens or pods, between Aug. 15, 2018, and Nov. 22, 2019, according to CPT Group, the case administrators. Curaleaf signed a definitive agreement to acquire Portland, Ore.-based Cura Partners and its Select brand in May 2019 in a $948.8-million all-stock deal. Curaleaf completed that acquisition in February 2020. The following year, Curaleaf became involved in a separate lawsuit for allegedly mislabeled products associated with a September 2021 recall by the Oregon Liquor and Cannabis Commission. Those products involved mislabeled CBD tinctures that actually contained THC. Those wishing to submit a claim for the recent settlement must do so by April 29, 2022. In addition to the online forms, claim forms are also available by writing to Cura Settlement, c/o CPT Group Inc., 50 Corporate Park, Irvine, CA 92606; or by emailing oregonclassactionsettlement@cptgroup.com . While the company denies it did anything wrong, and the circuit court for Multnomah County has not decided which side is right, the parties reached a $500,000 settlement . That money will provide $125,000 in plaintiff attorney fees as well as $200 for each approved claim, according to CPT Group. In addition, the defendant agreed to pay a $110,000 “dishonest conduct” penalty in January 2020, The Oregonian reported. The approximate costs of the allegedly mislabeled products at issue were $20, according to the settlement. Plaintiffs are entitled to back out of the settlement if the number of approved claims is so high that each class member would receive less than $20 each, according to the settlement. However, the settlement forecasts that fewer than 1% of those eligible will file claims because of the cash-only nature of Oregon sales as well as the products being sold through third-party retailers, The Oregonian reported. Those filing claims must show a proof of residency or proof of purchase in Oregon. The packaging on the eligible products did not include the existence of botanically derived terpenes and/or medium-chain triglyceride (MCT) as an ingredient in the product lines, according to CPT Group. Those with approved claims will receive an electronic payment or paper check. Any unclaimed funds will be split evenly between the Oregon State Bar and the Oregon Consumer League, a nonprofit advocacy organization focused on consumer protection issues
Chai Beckett, assistant manager at Buzz Box in Portland, Ore., considered a career in American Sign Language (ASL) before landing in the emerging cannabis industry. She had studied ASL in college, taking her coursework as far as she could, but then she found herself at a crossroads: What should she do professionally, after school? Cannabis won out, but she soon discovered that it wasn’t an either-or proposition. Last fall, Katalina B., founder of the advocacy group Human Informed Culture, reached out to Beckett to gauge her interest in a new set of ASL classes directed specifically at budtenders. Beckett jumped at the opportunity. It followed a sequence of events that had kept ASL at the very center of her life for years. “It just seemed like a really cool language to me,” she says, describing her ASL path. “I started getting really into the music scene, interpreting songs. And then it was like, ‘Why don't we have ASL taught at our school? We just have Spanish and French and German. We don't have ASL, but why not?’” From high school, where she petitioned administrators to add ASL as a course offering, through college, Beckett’s interest in the language bloomed. Then came the cannabis industry. The monthly ASL-for-cannabis classes are taught by Matt Maxey, founder of Deafinitely Dope. Prior to developing his three-tiered series of ASL classes for the cannabis space, Maxey brought his sign language skills to the music world. He’s worked with Waka Flocka Flame, Chance the Rapper and others to bring music to the hard of hearing. Maxey describes himself as “hard of hearing—severely profoundly hard of hearing.” He wears two hearing aids. “I can talk, but sign language does help to make things more clear—instead depending on technology,” he says. Music is important to him, so helping to bridge that language gap became a passion project. But so too is cannabis, and he found a way to bring his education skills to this new marketplace. “There is a genuine intent in learning how to be more accessible,” he says. “We're just trying to capitalize on that: Keep it moving, provide as many options as possible. But we’re still in the early stages.”
The demand is there, he’s quick to point out: “Everybody that I know who has a hearing loss indulges in marijuana,” he says with a laugh. In other words, for dispensary employees, it’s paramount to include that customer base’s needs in day-to-day operations. Buzz Box opened in March 2021, and Beckett says the dispensary prides itself on the surrounding neighborhood’s hyperlocal feel. It’s a tight-knit community. Dispensary interactions reflect that. “We really love to have a personalized experience with every customer and patient that comes in, which I love so much,” she says. “We just try to get specifics on what they're looking for so that we can give the right recommendations. With any category, like cartridges, extracts, flower, pre-rolls, it’s all about just asking those questions to make sure that they don't get something that's going to be too strong for them or not strong enough. We want to make sure that they know the right dosage and that it's the right effect that they're looking for.”
To do so, clear communication is required. Maxey’s classes get right to the matter at hand: framing ASL education with the typical words and phrases that make up an exchange inside a dispensary. “We learned things like ‘sativa,’ ‘hybrid,’ ‘indica,’” Beckett says. “We learned the different sizes—eighth, gram, quarter-ounce. We learned about different smells, like if it's ‘funky,’ if it's ‘sweet,’ if it's ‘lemony,’ different terpenes. Those words can really help cater the experience. Why should hearing people be the only ones to have these extraordinary experiences that are catered to them in dispensaries?”
Without the proper communication tools like ASL, deaf or partially deaf customers may be stuck merely pointing at menu items or going to the trouble of writing down their questions for the budtender. This can add a degree of discomfort to what is sometimes an already complicated commercial transaction. Cannabis can be a confusing product to navigate, especially for those who are new the market. Even knowing the basic alphabet signs can go a long way in welcoming customers who need sign language. Watch this video to learn from Maxey:
Maxey has seen a lot of success so far. ASL isn’t super difficult to learn, and budtenders have joined his classes with hopes of bringing the work back to their teams. He says Deafinitely Dope has worked with budtenders all over the U.S., across a variety of medical and adult-use markets. Demand is everywhere, even if it’s not as straightforward as it seems on first blush. “Deafness is a spectrum,” he says. “It’s not one-size-fits-all. You may have people who have hearing loss and don't know sign language. You may have people who have hearing loss and only use sign language. You may have people who really can't hear, but can hear a lot with their hearing aid. All of that is still included in the spectrum. Whether they talk, don't talk, whether they sign, they’re always trying to figure out how to communicate with you. Never assume that, ‘Oh, you’re deaf? You know sign language.’”
It's a matter of meeting customers and patients where they feel most comfortable, and being prepared to do so. PALMDESERT, Calif., March 1, 2022 – PRESS RELEASE – Cannabis 21+ , a premier family, women, veteran andprivately owned licensed cannabis dispensary operator in California, hasexpanded again, opening its largest store yet in Palm Desert. This is the firstof seven Riverside County locations set to open in the next 18 months. "Weknow how to run high-volume stores, as our San Diego SDRC-branded locationsserve almost 1,500 customers per day, but we've never had the square footageand service options that this new location offers,” said CEO Sean St. Peter,co-founder of Cannabis 21+. “Coachella Valley residents and tourists will bedelighted by the variety and value we are bringing to the community, including sixlarge kiosks that our supply partners will staff to highlight the benefits oftheir product lines." ManagerNick Smith added "Cannabis dispensaries should provide all the value ofstorefront retail-like, face-to-face assistance, product education and instantaccess to products. We strive to make shopping for cannabis fun, fast andbudget-friendly, without any of the hassles or worries some associate withcannabis. Our stores are bright, open and have plenty of parking, gettingpeople aged 21 and above back to their daily lives with a smile on their face whetherthey are brand new to cannabis or long-time consumers." Thislatest edition of what is expected to be 20 locations by the end of 2023 tookover two years to get permitted by Riverside County officials and remodeledwhat was originally constructed as a boutique grocery store. Cannabis 21+ PalmDesert has 15 stations where visitors are offered one-on-one privateconsultation covering the 1,500-plus products it will carry. Cannabis21+ prides itself on being a "deal store," which only carries itemsit can offer at the lowest price for one unit, and the value gets greater whencustomers tap into their daily deals and bundled offers which its well-trainedbudtenders go over in a fun and fast fashion. "Wehelped create the reputation for many of California's biggest brands and stillsupport them, but we also like give innovative new companies an opportunity tosucceed, which our customers love," St. Peter said. Thenew Palm Desert Market is located at 39225 Washington St., Palm Desert,California 92211. For more information, visit ShopC21plus.

Oregon Cannabis Customers Can Collect $200 Per Claim Over Select Brand’s Mislabeled Product Settlement

Class action settlement checks of up to $200 each will soon be sent to Oregon consumers who bought certain mislabeled marijuana vapes from Cura Partners in 2018 and 2019.
Marijuana vape customers to get up to $200 each in Oregon class action case is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Marijuana vape customers to get up to $200 each in Oregon class action case

Class action settlement checks of up to $200 each will soon be sent to Oregon consumers who bought certain mislabeled marijuana vapes from Cura Partners in 2018 and 2019. Marijuana vape customers to get up to $200 each in Oregon class action case is a post from: MJBizDaily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Cronos Group (NASDAQ: CRON) (TSXV: MJN) (OTC: PRMCF) is a holding company for Licensed Producers under Canada's Marihuana for Access to Cannabis for Medical Purposes Regulations ("ACMPR"). Cronos Group is focused on building brands that providing patients with compassionate, personalized care.

Cronos Group

Cronos Group Inc. announced that it has entered into a supply agreement with Cura .

The Daily Hit: August 9, 2018

Lenitiv manufactures beauty products. It is based in Tokyo, Japan.

Lenitiv

GB Sciences combines cannabis cultivation and biopharmaceutical research and development. The company offers technologies in plant biology, cultivation and post-production processes in order to optimize safe, consistent medical cannabis.

GB Sciences

Red Roof Inn

Eaze

Onshape

Datto

Pwnie Express

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.

Cannabis

Acquired

Cura Partners provides cannabis oil to both consumers and premium edible brands in legal US and international markets.On May 1st, 2019, Cura Partners was acquired by Curaleaf Holdings at a valuation between $949M and $1.15B.

Name	Work History	Title	Status
Cameron Forni		Chief Executive Officer, President	Current
Angelo Lombardi	Red Roof Inn	Chief Operating Officer	Former
Chris Essler	Eaze, Onshape, Datto, and Pwnie Express	Senior Vice President	Former

Name	Cameron Forni	Angelo Lombardi	Chris Essler
Work History		Red Roof Inn	Eaze, Onshape, Datto, and Pwnie Express
Title	Chief Executive Officer, President	Chief Operating Officer	Senior Vice President
Status	Current	Former	Former

Wells Fargo Success Story

3M Success Story

Platform Overview

Cura Partners

Executives

Cura Partners Management Team

3 Team Members

Discover the right solution for your team